Methylsulfonylmethane and boswellic acids similar to glucosamine sulfate in knee OA .
Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial
Int J Immunopathol Pharmacol. 2016 Mar;29(1):140-6120 patients with K-L grade III knee osteoarthritis were randomized to receive either glucosamine sulfate or a combination of methylsulfonylmethane and boswellic acids. The purpose of the study was to determine if the dual agent treatment was superior to the routinely used glucosamine sulfate in terms of pain and function outcomes. The findings of this study displayed comparable pain intensity, consumption of pain medication, and Lequesne Index scores between groups. Further trials that utilize patient and assessor blinding are needed to evaluate this combination treatment in comparison to both active comparators and a placebo treatment.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
